BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 32517658)

  • 1. Risk factors for and clinical outcomes of carbapenem non-susceptible gram negative bacilli bacteremia in patients with acute myelogenous leukemia.
    Shin DH; Shin DY; Kang CK; Park S; Park J; Jun KI; Kim TS; Koh Y; Hong JS; Choe PG; Park WB; Kim NJ; Yoon SS; Kim I; Oh MD
    BMC Infect Dis; 2020 Jun; 20(1):404. PubMed ID: 32517658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors and outcomes for the acquisition of carbapenem-resistant Gram-negative bacillus bacteremia: A retrospective propensity-matched case control study.
    Ting SW; Lee CH; Liu JW
    J Microbiol Immunol Infect; 2018 Oct; 51(5):621-628. PubMed ID: 28732563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Features and Risk Factors for Development of Breakthrough Gram-Negative Bacteremia during Carbapenem Therapy.
    Lee JY; Kang CI; Ko JH; Lee WJ; Seok HR; Park GE; Cho SY; Ha YE; Chung DR; Lee NY; Peck KR; Song JH
    Antimicrob Agents Chemother; 2016 Nov; 60(11):6673-6678. PubMed ID: 27572416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular characterization and risk factors for carbapenem-resistant Gram-negative bacilli colonization in children: emergence of NDM-producing Acinetobacter baumannii in a newborn intensive care unit in Turkey.
    Karaaslan A; Soysal A; Altinkanat Gelmez G; Kepenekli Kadayifci E; Söyletir G; Bakir M
    J Hosp Infect; 2016 Jan; 92(1):67-72. PubMed ID: 26601601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of clinical characteristics of bacteremia from Elizabethkingia meningoseptica and other carbapenem-resistant, non-fermenting Gram-negative bacilli at a tertiary medical center.
    Huang YC; Wu PF; Lin YT; Wang FD
    J Microbiol Immunol Infect; 2019 Apr; 52(2):304-311. PubMed ID: 30097388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors for nosocomial rectal colonisation with carbapenem-resistant Gram-negative bacilli in children with haematological malignancies: a case-control study.
    Fang C; Zhou Z; Zhou M; Li J
    Ann Clin Microbiol Antimicrob; 2023 Aug; 22(1):66. PubMed ID: 37537568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictive factors for sepsis by carbapenem resistant Gram-negative bacilli in adult critical patients in Rio de Janeiro: a case-case-control design in a prospective cohort study.
    Lima EM; Cid PA; Beck DS; Pinheiro LHZ; Tonhá JPS; Alves MZO; Lourenço ND; Santos RQ; Asensi MD; Marques JA; Bandeira CS; Rodrigues CAS; Gomes Junior SCS; Gomes MZR;
    Antimicrob Resist Infect Control; 2020 Aug; 9(1):132. PubMed ID: 32795380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment and Outcome of Carbapenem-Resistant Gram-Negative Bacilli Blood-Stream Infections in a Tertiary Care Hospital.
    Shah PG; Shah SR
    J Assoc Physicians India; 2015 Jul; 63(7):14-8. PubMed ID: 26731822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors for carbapenem-resistant Gram-negative bacteremia in intensive care unit patients.
    Routsi C; Pratikaki M; Platsouka E; Sotiropoulou C; Papas V; Pitsiolis T; Tsakris A; Nanas S; Roussos C
    Intensive Care Med; 2013 Jul; 39(7):1253-61. PubMed ID: 23604133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of clinical outcomes in patients with bloodstream infections due to Gram-negative bacteria according to carbapenem MIC stratification.
    Esterly JS; Wagner J; McLaughlin MM; Postelnick MJ; Qi C; Scheetz MH
    Antimicrob Agents Chemother; 2012 Sep; 56(9):4885-90. PubMed ID: 22777044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors and outcomes for multidrug-resistant Gram-negative bacteremia in the NICU.
    Tsai MH; Chu SM; Hsu JF; Lien R; Huang HR; Chiang MC; Fu RH; Lee CW; Huang YC
    Pediatrics; 2014 Feb; 133(2):e322-9. PubMed ID: 24420803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical characteristics and antimicrobial therapy of healthcare-associated carbapenem-non-susceptible gram-negative bacterial meningitis: a 16-year retrospective cohort study.
    Xu J; Du X; Li D; Li P; Guo Q; Xu X; Hu F; Wang M
    BMC Infect Dis; 2024 Apr; 24(1):368. PubMed ID: 38566040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carbapenem-resistant gram-negative bacterial infection in intensive care unit patients: Antibiotic resistance analysis and predictive model development.
    Liao Q; Feng Z; Lin H; Zhou Y; Lin J; Zhuo H; Chen X
    Front Cell Infect Microbiol; 2023; 13():1109418. PubMed ID: 36794004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carbapenem-resistant versus carbapenem-susceptible Acinetobacter baumannii bacteremia in a Greek intensive care unit: risk factors, clinical features and outcomes.
    Routsi C; Pratikaki M; Platsouka E; Sotiropoulou C; Nanas S; Markaki V; Vrettou C; Paniara O; Giamarellou H; Roussos C
    Infection; 2010 Jun; 38(3):173-80. PubMed ID: 20224962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gram-negative bacilli bacteremia: a 7 year retrospective study in a referral Brazilian tertiary-care teaching hospital.
    Quillici MCB; Resende DS; Gonçalves IR; Royer S; Sabino SS; Almeida VF; Ribas RM; Gontijo Filho PP
    J Med Microbiol; 2021 Jan; 70(1):. PubMed ID: 33258755
    [No Abstract]   [Full Text] [Related]  

  • 16. Bloodstream gram-negative bacterial infections in adult patients with leukemia: A retrospective review of medical records in a tertiary care hospital in Western Saudi Arabia.
    Merdad R; Alyami A; Basalim A; Alzahrani A; Aldainiy A; Awadh A; Ghulam E; Farahat F
    J Infect Public Health; 2023 Oct; 16(10):1525-1530. PubMed ID: 37557008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and Microbiological Outcomes in Obese Patients Receiving Colistin for Carbapenem-Resistant Gram-Negative Bloodstream Infection.
    Lam SW; Athans V
    Antimicrob Agents Chemother; 2019 Sep; 63(9):. PubMed ID: 31235624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for mortality in patients with carbapenem-resistant Acinetobacter baumannii bacteremia: impact of appropriate antimicrobial therapy.
    Kim YJ; Kim SI; Hong KW; Kim YR; Park YJ; Kang MW
    J Korean Med Sci; 2012 May; 27(5):471-5. PubMed ID: 22563209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for acute kidney injury in critically ill patients with bacteraemia by carbapenem non-susceptible Gram negative bacteria.
    Papadimitriou-Olivgeris M; Assimakopoulos SF; Kolonitsiou F; Solomou A; Vamvakopoulou S; Spyropoulou A; Karamouzos V; Anastassiou ED; Papachristou E; Spiliopoulou I; Christofidou M; Fligou F; Marangos M
    Infez Med; 2019 Dec; 27(4):380-392. PubMed ID: 31846987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors influencing mortality in abdominal solid organ transplant recipients with multidrug-resistant gram-negative bacteremia.
    Qiao B; Wu J; Wan Q; Zhang S; Ye Q
    BMC Infect Dis; 2017 Feb; 17(1):171. PubMed ID: 28241746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.